Dr.ย Mohamad Faridย Bin Harunal Rashid
MBBS, MRCP (UK), M Med (Internal Medicine)
Senior Consultant, Medical Oncology
corporate_fareNational Cancer Centre Singapore
Mohamad Farid Bin Harunal Rashid
MBBS, MRCP (UK), M Med (Internal Medicine)
Clin Assoc Prof Mohamad Farid Bin Harunal Rashid is a Senior Consultant in Medical Oncology at the National Cancer Centre Singapore (NCCS) and a Clinical Associate Professor at Duke-NUS Medical School. He specialises in rare and complex cancers including soft tissue sarcoma, gastrointestinal stromal tumours (GIST), melanoma, and skin cancer.
Dr. Mohamad Farid is a member of the NCCS paediatrics, sarcoma, and melanoma workgroup for Cancer Service Line Development, and was instrumental in establishing the NCCS sarcoma and GIST clinical database. His research interests focus on clinicopathologic correlations to better understand sarcoma biology and on strategies to improve outcomes of systemic therapy in sarcoma. He holds concurrent appointments as Senior Consultant at the SingHealth Duke-NUS Blood Cancer Centre and as an academic faculty member at Duke-NUS. His publication record spans angiosarcoma, leiomyosarcoma, malignant peripheral nerve sheath tumours, and melanoma outcomes in Asian populations.
CancerFax can coordinate medical-report review and consultation support for international patients seeking an opinion from specialists at National Cancer Centre Singapore.
Why Consider Dr. Mohamad Farid?
Dr. Mohamad Farid brings focused expertise in sarcoma, GIST, and melanoma โ rare cancers that require highly individualised, research-informed treatment planning.
Areas of Specialisation
Focused expertise in sarcoma, GIST, melanoma, and rare complex cancers through NCCS multidisciplinary care pathways.
Dr. Mohamad Farid's practice covers rare and complex solid tumours including soft tissue sarcomas, GIST, melanoma, and skin cancer. His clinical approach integrates tumour biology, clinicopathologic correlations, and systemic therapy planning within a structured, multidisciplinary oncology setting.
Sarcoma & Gastrointestinal Stromal Tumours
Comprehensive medical oncology care for soft tissue sarcomas and GIST, guided by tumour biology and clinicopathologic evidence.
- arrow_rightMedical oncology assessment and systemic therapy planning for soft tissue sarcoma subtypes
- arrow_rightClinicopathologic correlative evaluation to guide treatment decisions
- arrow_rightRecognised subtypes including angiosarcoma, leiomyosarcoma, and malignant peripheral nerve sheath tumours
- arrow_rightInvolvement in the NCCS sarcoma and GIST clinical database
- arrow_rightSystemic therapy coordination for GIST in conjunction with surgical and multidisciplinary teams
- arrow_rightTreatment planning based on tumour profile and disease extent
Melanoma & Skin Cancer
Medical oncology care for melanoma and skin cancers, with research contributions to outcomes data in Asian patient populations.
- arrow_rightListed specialty and treated condition at NCCS
- arrow_rightPublished research on treatment and outcomes of melanoma in Asia
- arrow_rightMember of NCCS paediatrics, sarcoma, and melanoma workgroup
- arrow_rightVerified treated condition at NCCS
- arrow_rightMedical oncology evaluation and systemic therapy planning for selected skin malignancies
Procedures Performed
Systemic cancer care, multidisciplinary planning, and second-opinion review for rare and complex solid tumours
As a medical oncologist at NCCS, Dr. Mohamad Farid focuses on systemic therapy planning, tumour biology-guided treatment decisions, and multidisciplinary care coordination for sarcoma, GIST, and melanoma.
Systemic Therapy for Sarcoma & GIST
Medical OncologyMedical oncology assessment and systemic treatment planning for soft tissue sarcoma subtypes and GIST.
Melanoma & Skin Cancer Medical Oncology
Medical OncologySystemic oncology care for melanoma and skin cancer, including evaluation and treatment planning.
Multidisciplinary Cancer Care
MultidisciplinaryCollaborative care within the NCCS sarcoma, melanoma, and paediatric oncology workgroup.
Second Opinion & Complex Case Review
Second OpinionSpecialist second-opinion assessment for sarcoma, GIST, melanoma, and skin cancer, supported through NCCS pathways.
Research & Publications
Peer-reviewed contributions in sarcoma biology, melanoma outcomes, and rare tumour oncology
Dr. Mohamad Farid has a visible academic profile in sarcoma and melanoma oncology research, with publications in Oncology and The Oncologist, and an active Google Scholar citation record exceeding 1,700 citations. His research themes include clinicopathologic studies of sarcoma subtypes, outcomes research in Asian populations, and sarcoma-related genetic predisposition syndromes.
Dr. Mohamad Farid's research is indexed on Google Scholar with over 1,700 citations. A more detailed publication list is available through his NCCS and Duke-NUS academic profiles.
Education & Training
Dr. Mohamad Farid completed his medical training at the National University of Singapore and obtained his specialist membership from the Royal College of Physicians, United Kingdom.
Clinical Experience
Dr. Mohamad Farid has built his specialist oncology career at the National Cancer Centre Singapore, holding concurrent roles in clinical practice, academic medicine, and cancer service development.
Languages & International
Dr. Mohamad Farid consults in the following languages.
CancerFax can coordinate professional medical interpreter support for international patients consulting at National Cancer Centre Singapore.
CancerFax can coordinate professional medical interpreter support for international patients when required.
How CancerFax Helps You Access Dr. Mohamad Farid Bin Harunal Rashid
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Mohamad Farid Bin Harunal Rashid's team โ with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history โ prepared as a structured clinical summary for Dr. Mohamad Farid Bin Harunal Rashid's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Mohamad Farid Bin Harunal Rashid before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Mohamad Farid Bin Harunal Rashid's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Mohamad Farid Bin Harunal Rashid's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Mohamad Farid Bin Harunal Rashid's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Dr. Mohamad Farid
Dr. Mohamad Farid specialises in medical oncology with a clinical focus on soft tissue sarcoma, gastrointestinal stromal tumour (GIST), melanoma, and skin cancer. His practice also covers rare sarcoma subtypes including angiosarcoma, leiomyosarcoma, and malignant peripheral nerve sheath tumours, as well as sarcomas associated with genetic cancer predisposition syndromes.
Dr. Mohamad Farid is a Senior Consultant in Medical Oncology at the National Cancer Centre Singapore (NCCS) and a Senior Consultant at the SingHealth Duke-NUS Blood Cancer Centre. He also holds an academic appointment as Clinical Associate Professor at Duke-NUS Medical School.
CancerFax can coordinate medical-report review and consultation support for international patients seeking an opinion from Dr. Mohamad Farid at the National Cancer Centre Singapore, subject to hospital availability and case acceptance. Please submit your reports through the CancerFax portal for initial review.
A second-opinion request can be submitted through CancerFax with the patient's pathology reports, imaging studies, treatment history, and relevant test results. The CancerFax team will prepare the case and coordinate the next steps with the hospital, subject to the doctor's availability and institution protocols.
Dr. Mohamad Farid holds an MBBS from the National University of Singapore, a Master of Medicine in Internal Medicine from the National University of Singapore, and Membership of the Royal College of Physicians, United Kingdom (MRCP UK).
Yes. Dr. Mohamad Farid has published peer-reviewed research on sarcoma biology, angiosarcoma, leiomyosarcoma, malignant peripheral nerve sheath tumours, melanoma outcomes in Asia, and sarcomas associated with genetic predisposition syndromes. He was also involved in establishing the NCCS sarcoma and GIST clinical database and has an active Google Scholar profile with over 1,700 citations.
Connect with Mohamad Farid Bin Harunal Rashid Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.